Xiaolu Tao

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.

Li-an Xu, M. Yellin, G. Nichol, 2012, Arthritis and rheumatism.

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

W. Sandborn, L. Mayer, L. Salter-Cid, 2013, Gut.